Skip to content

A study of frailty in head neck cancer patients & its impact on treatment outcomes

A prospective cohort study of frailty in head neck cancer patients & its impact on treatment outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033617
Enrollment
100
Registered
2021-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

None listed

Sponsors

Tata memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with head neck cancer of oral cavity, larynx, hypopharynx, oropharynx. 2. Age > 60 years 3. Patient able to comprehend the test procedure & perform the test requirements 4. Willing to give written informed consent.

Exclusion criteria

Exclusion criteria: 1. Unstable Angina or recent (within the last 3 months) myocardial infarction, Uncontrolled arrhythmias, persistent uncontrolled hypertension (systolic blood pressure >180â??mm Hg or diastolic blood pressure >110â??mm Hg). 2. Recent (within the last 3 months) stroke or transient is chaemic attack. 3. Patient with severe visual impairment i.e Visual acuity of less than 3 / 60 with a full visual field with the help of corrective glasses. 4. Unable to mobilize independently (with /without walking aids)due to severe joint issues (eg osteoarthritis) or giddiness / generalized weakness/vertigo 5. Patients taking treatment outside TMH

Design outcomes

Primary

MeasureTime frame
1. To study the prevalence of frailty in head neck cancer patients planned for curative intent treatment.Timepoint: 2 years

Secondary

MeasureTime frame
1. To study the association frailty with treatment intent/change in standard treatment plan 2.To study the impact of frailty on 30 day surgical morbidity & other complications. 3. To study the normative values of the TUG test in Indian older patients & its correlation with FFP 4. To compare the ability of Charlsonâ??s comorbidity index & ASA status for predicting peri/postoperative complications with frailty index. 5. To study the impact of frailty on completion of treatment Timepoint: 2years

Countries

India

Contacts

Public ContactDr Vidisha Tuljapurkar

Head & Neck Surgical Oncology

vidishavt@yahoo.com9930119628

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026